Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Marie  Lafleur

Marie Lafleur

Partner Fasken
Biologicals, a new class of pharmaceutical products, are booming in Canada.
Jurisdiction Quebec, 1983
Language(s) French, English
Office(s) Montreal
Contact

Marie Lafleur is a seasoned intellectual property litigator. She regularly appears before the courts in proceedings under the Patented Medicines (Notice of Compliance) Regulations and litigation concerning pharmaceutical patent infringement or invalidity.  Her expertise encompasses biologicals and biosimilars.

 

Marie has represented numerous companies in proceedings to prevent the Minister of Health from issuing Notices of Compliance that would allow generic versions of patented drugs to be sold, including citalopram, escitalopram, doxylamine/pyridoxine, cyclosporin, omeprazole, diltiazem, divalproex and terazosin.  

She has also successfully filed numerous applications to add or remove patents from the Health Canada register.  She was involved in many applications for judicial review of various decisions by provincial and federal health ministers.

Marie’s expertise covers every extraordinary remedy, particularly seizures before judgment and injunctions, and she fully masters the range of alternative dispute resolution mechanisms available.

Date

Education

  • Various courses, D.E.S.S., Drug Development, Faculty of Pharmacy University of Montréal
  • M.B.A. Concordia University
  • BCL McGill University
  • LLB McGill University

Memberships & Affiliations

  • Member, Québec Bar
  • Member, Bar of Montréal
  • Member, Canadian Bar Association
  • Fellow Member, Intellectual Property Institute of Canada
Data Protection location location Montréal
Fasken Training Day Program
Best Practices in NOC proceedings location location Ottawa

    Subscribe

    Receive email updates from our team

    Subscribe